BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33206735)

  • 1. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
    Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
    Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cascade Immune Activation of Self-Delivery Biomedicine for Photodynamic Immunotherapy Against Metastatic Tumor.
    Zheng RR; Zhao LP; Yang N; Chen ZX; Kong RJ; Huang CY; Rao XN; Chen X; Cheng H; Li SY
    Small; 2023 Jan; 19(3):e2205694. PubMed ID: 36366925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
    Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway.
    Yang X; Zhang W; Jiang W; Kumar A; Zhou S; Cao Z; Zhan S; Yang W; Liu R; Teng Y; Xie J
    J Nanobiotechnology; 2021 Jun; 19(1):182. PubMed ID: 34127005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen-boosted biomimetic nanoplatform for synergetic phototherapy/ferroptosis activation and reversal of immune-suppressed tumor microenvironment.
    He Z; Zhou H; Zhang Y; Du X; Liu S; Ji J; Yang X; Zhai G
    Biomaterials; 2022 Nov; 290():121832. PubMed ID: 36228518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
    Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
    Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumor-microenvironment fully responsive nano-platform for MRI-guided photodynamic and photothermal synergistic therapy.
    Wang D; Zhang N; Jing X; Zhang Y; Xu Y; Meng L
    J Mater Chem B; 2020 Sep; 8(36):8271-8281. PubMed ID: 32812996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Janus upconverting nanoplatform with biodegradability for glutathione depletion, near-infrared light induced photodynamic therapy and accelerated excretion.
    Zhou H; Li Q; Cheng X; Zhang C; Sun J; Du L; Cao J; Liu Y; Huang P
    J Mater Chem B; 2020 Oct; 8(40):9251-9257. PubMed ID: 32929430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer.
    Wu H; Du X; Xu J; Kong X; Li Y; Liu D; Yang X; Ye L; Ji J; Xi Y; Zhai G
    Acta Biomater; 2023 Feb; 157():551-565. PubMed ID: 36513248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate.
    Lu Y; Xu F; Wang Y; Shi C; Sha Y; He G; Yao Q; Shao K; Sun W; Du J; Fan J; Peng X
    Biomaterials; 2021 Nov; 278():121167. PubMed ID: 34624752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
    Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
    Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Responsive Multifunctional Nanoplatform Based on Peptide Self-Assembly for Highly Efficient Combined Cancer Therapy by Alleviating Hypoxia and Improving the Immunosuppressive Microenvironment.
    Wu J; Liu Y; Cao M; Zheng N; Ma H; Ye X; Yang N; Liu Z; Liao W; Sun L
    ACS Appl Mater Interfaces; 2023 Feb; 15(4):5667-5678. PubMed ID: 36651290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
    Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
    Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light-responsive hyaluronic acid nanomicelles co-loaded with an IDO inhibitor focus targeted photoimmunotherapy against "immune cold" cancer.
    Wu C; Xu J; Xie Z; Huang H; Li N; Wei X; Li T; Yang H; Li S; Qin X; Liu Y
    Biomater Sci; 2021 Nov; 9(23):8019-8031. PubMed ID: 34718362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An 808 nm Light-Sensitized Upconversion Nanoplatform for Multimodal Imaging and Efficient Cancer Therapy.
    Gulzar A; Wang Z; He F; Yang D; Zhang F; Gai S; Yang P
    Inorg Chem; 2020 Apr; 59(7):4909-4923. PubMed ID: 32162905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-shell structured upconversion nanocarriers that combine IDO inhibitor-induced immunotherapy with NIR-triggered photodynamic therapy for deep tumors.
    Choi J; Kim SY
    Biomater Sci; 2023 Jun; 11(13):4684-4699. PubMed ID: 37219321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light-inducible nanodrug-mediated photodynamic and anti-apoptotic synergy for enhanced immunotherapy in triple-negative breast cancer.
    Huang J; Liu X; Lin M; Xiao Z; Shuai X
    Biomater Sci; 2024 May; 12(10):2639-2647. PubMed ID: 38563394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
    Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
    ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.